Thermal sensitivity as a measure of spontaneous morphine withdrawal in mice

Journal of Pharmacological and Toxicological Methods

Volumn 67, Issue 3, 2013, Pages 162-168

  Balter, Rebecca E ^a   Dykstra, Linda A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

Jumping; Methods; Morphine; Mouse; Spontaneous withdrawal; Thermal sensitivity

Indexed keywords

BUPRENORPHINE; MORPHINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DATA ANALYSIS; HOT PLATE TEST; JUMPING; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PARALLEL DESIGN; SENSITIVITY ANALYSIS; TEMPERATURE SENSITIVITY; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; BUPRENORPHINE; HOT TEMPERATURE; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NARCOTIC ANTAGONISTS; PAIN THRESHOLD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84875264522     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2013.02.003     Document Type: Article

References (31)

1. Angst M.S., Koppert W., Pahl I., Clark D.J., Schmeiz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003, 106:49-57.
2. Balter R.E., Dykstra L.A. The effect of environmental factors on morphine withdrawal in C57BL/6J mice: running wheel access and group housing. Psychopharmacology 2012, 224(1):91-100.
3. Compton P., Athanasos P., Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in non addicted humans: a preliminary study. The Journal of Pain 2003, 4:511-519.
4. Connock M., Juarez-Garcia A., Jowett S., Frew E., Liu Z., Taylor R.J., et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment 2007, 11(9):1-171. (iii-iv. Review).
5. Crain S.M., Shen K.F. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice. Brain Research 2007, 1167:31-34.
6. Devillers J.P., Boisserie F., Laulin J.P., Larcher A., Simonnet G. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Research 1995, 700:173-181.
7. Devulder J., Bohyn P., Castille F., De Laat M., Rolly G. A case of uncommon withdrawal symptoms after a short period of spinal morphine administration. Pain 1996, 64(3):589-591.
8. Dunbar S.A., Pulai I.J. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. The Journal of Pharmacology and Experimental Therapeutics 1998, 284:678-686.
9. Elmer G.I., Pieper J.O., Hamilton L.R., Wise R.A. Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration. Psychopharmacology 2010, 208(2):309-321.
10. Fischer B.D., Zimmerman E.I., Picker M.J., Dykstra L.A. Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception. The Journal of Pharmacology and Experimental Therapeutics 2008, 324(2):732-739.
11. Grilly D.M., Gowans G.C. Acute morphine dependence: effects observed in shock and light discrimination tasks. Psychopharmacology 1986, 88(4):500-504.
12. Jin H., Li Y.H., Xu J.S., Guo G.Q., Chen D.L., Bo Y. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat. Neuroscience 2012, 208:1-10.
13. Johnson S.M., Duggan A.W. Tolerance and dependence of dorsal horn neurones of the cat: the role of the opiate receptors of the substantia gelatinosa. Neuropharmacology 1981, 20(11):1033-1038.
14. Kest B., Palmese C.A., Hopkins E., Adler M., Juni A.J., Mogil J.S. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 2002, 115:463-469.
15. Kraus M.L., Alford D.P., Kotz M.M., Levounis P., Mandell T.W., Meyer M., et al. American Society Of Addiction Medicine: Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. Journal of Addictive Medicine 2011, 5(4):254-263.
16. Laulin J.P., Larcher A., Célèrier E., Le Moal M., Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. The European Journal of Neuroscience 1998, 10(2):782-785.
17. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesthesia and Analgesia 2002, 94(5):1263-1269.
18. Le Moal M., Koob G.F. Drug addiction: pathways to the disease and pathophysiological perspectives. European Neuropsychopharmacology 2007, 17(6-7):377-393.
19. Li X., Angst M.S., Clark J.D. Opioid-induced hyperalgesia and incisional pain. Anesthesia and Analgesia 2001, 93(1):204-209.
20. Lipman J.J., Blumenkopf B. Comparison of subjective and objective analgesic effects of intravenous and intrathecal morphine in chronic pain patients by heat beam dolorimetry. Pain 1989, 39(3):249-256.
21. Martin W.R., Gilbert P.E., Jasinski D.R., Martin C.D. An analysis of naltrexone precipitated abstinence in morphine-dependent chronic spinal dogs. The Journal of Pharmacology and Experimental Therapeutics 1987, 240(2):565-570.
22. Mogil J.S., Chesler E.J., Wilson S.G., Juraska J.M., Sternberg W.F. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neuroscience and Biobehavioral Reviews 2000, 24(3):375-389. (Review).
23. National Research Council Guide for the Care and Use of Laboratory Animals 2011, The National Academies Press, Washington, DC. Eighth Edition.
24. Papaleo F., Contarino A. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behavioural Brain Research 2006, 170(1):110-118.
25. Rubovitch V., Pick C.G., Sarne Y. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?. Addiction Biology 2009, 14(4):438-446.
26. Saelens J.K., Granat F.R., Sawyer W.K. The mouse jumping test-a simple screening method to estimate the physical dependence capacity of analgesics. Archives Internationales de Pharmacodynamie et de Thérapie 1971, 190:213-218.
27. Strain E.C., Harrison J.A., Bigelow G.E. Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films. Clinical Pharmacology and Therapeutics 2011, 89(3):443-449.
28. Sun H.L. Naloxone-precipitated acute opioid withdrawal syndrome after epidural morphine. Anesthesia and Analgesia 1998, 86(3):544-545.
29. Sweitzer S.M., Cp Allen, Zissen M.H., Kendig J.J. Mechanical allodynia and thermal hyperalgisia upon acute opioid withdrawal in the neonatual rat. Pain 2004, 110:269-280.
30. Tilson H.A., Rech R.H., Stolman S. Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia 1973, 28(3):287-300.
31. Tompkins D.A., Bigelow G.E., Harrison J.A., Johnson R.E., Fudala P.J., Strain E.C. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug and Alcohol Dependence 2009, 105(1-2):154-159.